HENDERSON, Nev., December 23, 2024--Zura Bio launches TibuSURE, a Phase 2 global study evaluating tibulizumab for the treatment of systemic sclerosis (SSc) in adults. HENDERSON, Nev., November 25 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback